The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / No Easy Solution for Lack of Transparency in the Practice of Medicine

No Easy Solution for Lack of Transparency in the Practice of Medicine

December 1, 2012 • By Simon M. Helfgott, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Dr. Helfgott, MD
Dr. Helfgott, MD

Consider this scenario: A research paper is written by two highly respected academics; one is a professor of law and economics at a prestigious university and the other is the dean of the business school at another major university. Entitled, “Competition in the Mutual Fund Industry: Evidence and Implications for Policy,” the paper lays out a strong defense of the mutual fund industry’s position on the pricing of fees for their services.1 Critics were accusing some mutual fund managers of gouging clients by charging them excessive fees. The professors countered that it would be impossible for fund managers to overcharge clients because their field was so highly competitive. After all, fund investors may, “fire advisers at any time by redeeming shares and switching into other investments.” The 36,000-word paper is elegantly written and provides a strong analytical argument in support of their conclusions. Buried in the fine print of the acknowledgments section, the authors thank many of their colleagues for their helpful comments, conversations, and data analysis. They casually acknowledge the Investment Company Institute (ICI), ICI Mutual, and the John M. Olin Center for Law, Economics, and Business at Harvard Law School for “providing financial assistance.” One of the authors is listed as having testified as an expert witness for a mutual-fund advisory company.

You Might Also Like
  • Malpractice Lawsuit Fear Provokes Defensive Medicine Response
  • Fallout from False Assumptions in Medicine
  • Ethical Concerns Influence What Constitutes Clear and Full Disclosure for Physicians
Explore This Issue
December 2012
Also By This Author
  • When Is a Doctor Too Old to Practice?

Though this paper is replete with a dizzying array of data, statistical analyses, and high-level calculus, there are no clues that hint at the degree of support they received from the mutual-fund industry. According to an article in the New York Times, the lead author, John C. Coates, IV, professor of law and economics at Harvard Law School in Cambridge, Mass., did not receive any financial support for his work.2 He stated that, as a matter of personal policy, he did not accept money in such circumstances for academic work. In contrast, the second author, R. Glenn Hubbard, dean and Russell L. Carson professor of finance and economics at the Graduate School of Business of Columbia University in New York City, appeared to have no qualms about accepting a $150,000 honorarium from the mutual-fund industry. In response to an e-mail request from the Times reporter seeking clarification for the size of this payment, Hubbard replied: “Any work of scholarship rises or falls on its ideas, empirical support, and argument. Readers can then make whatever judgment they wish.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The Times They Are a-Changing

Unfortunately for Professor Hubbard, his views on conflicts of interest (COIs) and transparency are woefully out of date. There is mounting concern that many academic and research activities lack transparency. In other words, there are too many “unknown unknowns.” Though changes in the rules and regulations pertaining to the management of conflicts have been moving at a glacial pace at some elite American business and law schools, this has not been the case for most medical schools and academic medical centers, where the need for more transparency has taken on a critical sense of urgency.

Pages: 1 2 3 4 5 | Single Page

Filed Under: Ethics, Legal, Legislation & Advocacy, Opinion, Practice Management, Professional Topics, Quality Assurance/Improvement, Rheuminations Tagged With: bone, Conflict of interest, drug, Ethics, Helfgott, Legal, Legislation, Practice Management, rheumatologist, transparencyIssue: December 2012

You Might Also Like:
  • Malpractice Lawsuit Fear Provokes Defensive Medicine Response
  • Fallout from False Assumptions in Medicine
  • Ethical Concerns Influence What Constitutes Clear and Full Disclosure for Physicians
  • What Rheumatologists Should Know about Purchasing a Healthcare Practice

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)